Alcohol Consumption Increases Risk Of Lobular And HR+ Breast Cancer
Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer
Brothers Of Prostate Cancer Patients At Risk Of Diagnosis
Estrogen Alone Didn’t Increase Lung Cancer Mortality In WHI
Tumors Harder To Detect In Women In Their Forties
Two Avastin Trials Show OS Benefit In Advanced Disease
Risk-Benefit Analysis Advised Prior To Hormone Therapy
Elderly Patients Fail To Receive New Cancer Therapy For CML
Rising Obesity May Result In Higher Cancer Incidence
Study Finds Relationship Between Meat Intake, Cancer
Radiation To Stem Cell Niche Improved PFS In Glioblastoma
NCI Cooperative Group Clinical Trials Approved
Trending Stories
- Federal judge blocks Trump administration’s move to limit indirect costs to 15% for NIH-funded institutions
The move could gut academic cancer research - FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - 20 years of EGFR research: Ramalingam, Carbone, Politi, Jänne, Govindan reflect
- Preparing to take care of each other in ways we never imagined
- On a new podcast, VCU’s Winn and City of Hope’s Carpten discuss the mission—and the future—of cancer centers
The Cancer Letter’s new podcast offers insight into cancer policy in a landscape of uncertainty
